Risk of medication overuse headache across classes of treatments for acute migraine
Kristian Thorlund(McMaster University), Stewart J. Tepper(New England Institute for Neurology and Headache), Shanil Ebrahim(McMaster University), Rahul Bhambri(Pfizer (United States)), Edward J. Mills(Africa Centres for Disease Control and Prevention), Steve Kanters(University of British Columbia), Christina Sun‐Edelstein(St Vincent's Hospital Melbourne), Eric Druyts(University of British Columbia), Élodie Ramos(Pfizer (United States)), Michel Lantéri‐Minet(Inserm)
Cited by 115
Related Papers
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
|Annals of Internal Medicine|2015|8.2k
Adherence to HAART: A Systematic Review of Developed and Developing Nation Patient-Reported Barriers and Facilitators
|PLoS Medicine|2006|823
GRADE guidelines: 13. Preparing Summary of Findings tables and evidence profiles—continuous outcomes
|Journal of Clinical Epidemiology|2012|761
Opioids for Chronic Noncancer Pain
|JAMA|2018|706